CIK 0002022416 · <br>Emerging growth company
Silexion Therapeutics Corp
Sign in to watch- Ticker
- SLXN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 972-8-6286005
- Business address
- 12 ABBA HILLEL ROAD, RAMAT GAN, Israel, 5250606
- Former names
- Biomotion Sciences
Securities
- SLXN Ordinary Shares Nasdaq
- SLXNW Warrant Nasdaq
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Regulation FD disclosure
- DRS Other Draft Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure · Other events
- S-1/A Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-K Report Annual Report
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Unregistered share sale
Page 10 of 15 · 283 filings